Advertisement

Topics

Regeneron Pharmaceuticals Profit Rises 48% In Q2

09:29 EDT 3 Aug 2017 | FinanzNachrichten

WASHINGTON (dpa-AFX) - Regeneron Pharmaceuticals (REGN) revealed earnings for its second quarter that rose compared to the same period last year.The company said its bottom line climbed to $487 mi...

Original Article: Regeneron Pharmaceuticals Profit Rises 48% In Q2

NEXT ARTICLE

More From BioPortfolio on "Regeneron Pharmaceuticals Profit Rises 48% In Q2"

Quick Search
Advertisement